Pfizer 2013 Annual Report Download - page 58

Download and view the complete annual report

Please find page 58 of the 2013 Pfizer annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 123

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123

Consolidated Balance Sheets
Pfizer Inc. and Subsidiary Companies
2013 Financial Report
57
As of December 31,
(MILLIONS, EXCEPT PREFERRED STOCK ISSUED AND PER COMMON SHARE DATA) 2013 2012
Assets
Cash and cash equivalents $2,183 $10,081
Short-term investments 30,225 22,318
Accounts receivable, less allowance for doubtful accounts: 2013—$478; 2012—$324 9,357 10,675
Inventories 6,166 6,076
Current deferred tax assets and other current tax assets 4,624 6,170
Other current assets 3,613 3,567
Assets of discontinued operations and other assets held for sale 76 5,944
Total current assets 56,244 64,831
Long-term investments 16,406 14,149
Property, plant and equipment, less accumulated depreciation 12,397 13,213
Goodwill 42,519 43,661
Identifiable intangible assets, less accumulated amortization 39,385 45,146
Noncurrent deferred tax assets and other noncurrent tax assets 1,554 1,565
Other noncurrent assets 3,596 3,233
Total assets $ 172,101 $185,798
Liabilities and Equity
Short-term borrowings, including current portion of long-term debt: 2013—$2,060; 2012—$2,449 $6,027 $6,424
Accounts payable 3,234 2,921
Dividends payable 1,663 1,733
Income taxes payable 678 979
Accrued compensation and related items 1,792 1,875
Other current liabilities 9,951 13,812
Liabilities of discontinued operations 21 1,442
Total current liabilities 23,366 29,186
Long-term debt 30,462 31,036
Pension benefit obligations, net 4,635 7,782
Postretirement benefit obligations, net 2,668 3,491
Noncurrent deferred tax liabilities 25,590 21,193
Other taxes payable 3,993 6,581
Other noncurrent liabilities 4,767 4,851
Total liabilities 95,481 104,120
Commitments and Contingencies
Preferred stock, no par value, at stated value; 27 shares authorized; issued: 2013—829; 2012—967 33 39
Common stock, $0.05 par value; 12,000 shares authorized; issued: 2013—9,051; 2012—8,956 453 448
Additional paid-in capital 77,283 72,608
Treasury stock, shares at cost: 2013—2,652; 2012—1,680 (67,923) (40,122)
Retained earnings 69,732 54,240
Accumulated other comprehensive loss (3,271)(5,953)
Total Pfizer Inc. shareholders’ equity 76,307 81,260
Equity attributable to noncontrolling interests 313 418
Total equity 76,620 81,678
Total liabilities and equity $ 172,101 $185,798
See Notes to Consolidated Financial Statements, which are an integral part of these statements.